e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
11 01 2021
Historique:
accepted: 20 10 2020
revised: 07 10 2020
received: 07 04 2020
pubmed: 20 11 2020
medline: 2 2 2021
entrez: 19 11 2020
Statut: ppublish

Résumé

Understanding the functional impact of cancer somatic mutations represents a critical knowledge gap for implementing precision oncology. It has been increasingly appreciated that the interaction profile mediated by a genomic mutation provides a fundamental link between genotype and phenotype. However, specific effects on biological signaling networks for the majority of mutations are largely unknown by experimental approaches. To resolve this challenge, we developed e-MutPath (edgetic Mutation-mediated Pathway perturbations), a network-based computational method to identify candidate 'edgetic' mutations that perturb functional pathways. e-MutPath identifies informative paths that could be used to distinguish disease risk factors from neutral elements and to stratify disease subtypes with clinical relevance. The predicted targets are enriched in cancer vulnerability genes, known drug targets but depleted for proteins associated with side effects, demonstrating the power of network-based strategies to investigate the functional impact and perturbation profiles of genomic mutations. Together, e-MutPath represents a robust computational tool to systematically assign functions to genetic mutations, especially in the context of their specific pathway perturbation effect.

Identifiants

pubmed: 33211847
pii: 5992298
doi: 10.1093/nar/gkaa1015
pmc: PMC7797045
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM133658
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA240689
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Neoplasma. 2009;56(2):136-40
pubmed: 19239328
BMC Med Genomics. 2015;8 Suppl 2:S11
pubmed: 26044366
FEBS J. 2015 Dec;282(24):4672-8
pubmed: 26432171
PLoS Comput Biol. 2012;8(9):e1002690
pubmed: 23028288
Cell. 2015 Apr 23;161(3):647-660
pubmed: 25910212
Trends Biochem Sci. 2019 Aug;44(8):659-674
pubmed: 31047772
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:125-31
pubmed: 23855308
Genome Biol. 2007;8(11):R232
pubmed: 17976239
Nat Rev Cancer. 2017 Aug 24;17(9):557-569
pubmed: 28835719
J Hepatol. 2012 Apr;56(4):952-64
pubmed: 22173168
Curr Opin Genet Dev. 2019 Feb;54:110-117
pubmed: 31288129
Cell Death Dis. 2018 Mar 14;9(3):402
pubmed: 29540729
Nat Rev Immunol. 2018 Mar;18(3):168-182
pubmed: 29226910
Nat Methods. 2013 Nov;10(11):1108-15
pubmed: 24037242
Cell. 2014 Nov 20;159(5):1212-1226
pubmed: 25416956
Nat Genet. 2015 Feb;47(2):106-14
pubmed: 25501392
Mol Syst Biol. 2007;3:152
pubmed: 18091723
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4164-9
pubmed: 15016911
Nat Methods. 2019 Jun;16(6):505-507
pubmed: 31110280
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Nat Rev Cancer. 2018 Nov;18(11):696-705
pubmed: 30293088
Mol Cell. 2016 Aug 18;63(4):579-592
pubmed: 27540857
Science. 2015 Sep 25;349(6255):1478-83
pubmed: 26404824
Cancer Cell. 2017 Feb 13;31(2):225-239
pubmed: 28196595
Database (Oxford). 2011 Sep 19;2011:bar026
pubmed: 21930502
Mol Cell Biol. 2018 Mar 15;38(7):
pubmed: 29339380
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Int J Mol Sci. 2015 Dec 29;17(1):
pubmed: 26729094
Cell. 2017 Jun 15;169(7):1327-1341.e23
pubmed: 28622513
Trends Biochem Sci. 2019 Jul;44(7):575-588
pubmed: 30712981
Trends Biochem Sci. 2018 Aug;43(8):576-592
pubmed: 29941230
Mol Syst Biol. 2009;5:321
pubmed: 19888216
Mol Syst Biol. 2013;9:663
pubmed: 23632385
Nature. 2014 Jan 23;505(7484):495-501
pubmed: 24390350
Cancer Discov. 2016 Aug;6(8):914-29
pubmed: 27260156
Cell Syst. 2015 Oct 28;1(4):251-3
pubmed: 27136053
Nat Protoc. 2017 Nov;12(11):2323-2341
pubmed: 28981122
Cell. 2011 Mar 18;144(6):986-98
pubmed: 21414488
Cancer Cell. 2018 Mar 12;33(3):450-462.e10
pubmed: 29533785
BMC Bioinformatics. 2012 Jun 07;13:126
pubmed: 22676414
Mol Oncol. 2007 Jun;1(1):55-71
pubmed: 19383287
J Clin Invest. 2017 May 1;127(5):1873-1888
pubmed: 28394260
Nat Methods. 2018 Jan;15(1):61-66
pubmed: 29200198
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Genome Res. 2001 May;11(5):863-74
pubmed: 11337480
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
PLoS Comput Biol. 2014 Feb 06;10(2):e1003460
pubmed: 24516372
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Nat Rev Genet. 2017 Jul;18(7):395-410
pubmed: 28344341
Cell Mol Life Sci. 2007 Jul;64(14):1752-62
pubmed: 17415519
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Cancer Res. 2015 Sep 15;75(18):3728-37
pubmed: 26208906
Genome Biol. 2016 Jun 23;17(1):129
pubmed: 27333808
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Nat Methods. 2013 Nov;10(11):1046-7
pubmed: 24037243
Cell. 2016 Feb 11;164(4):805-17
pubmed: 26871637
Nat Methods. 2017 Dec;14(12):1213-1221
pubmed: 29039417
Cell. 2015 Apr 23;161(3):661-673
pubmed: 25910213
Oncotarget. 2016 Nov 29;7(48):78841-78849
pubmed: 27791983
Hepatology. 2019 Aug;70(2):532-546
pubmed: 30153342

Auteurs

Yongsheng Li (Y)

Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Oden Institute for Computational Engineering and Sciences (ICES), The University of Texas at Austin, Austin, TX 78712, USA.

Brandon Burgman (B)

Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Interdisciplinary Life Sciences Graduate Programs (ILSGP), College of Natural Sciences, The University of Texas at Austin, Austin, TX 78712, USA.

Ishaani S Khatri (IS)

Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Oden Institute for Computational Engineering and Sciences (ICES), The University of Texas at Austin, Austin, TX 78712, USA.

Sairahul R Pentaparthi (SR)

Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.

Zhe Su (Z)

Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Oden Institute for Computational Engineering and Sciences (ICES), The University of Texas at Austin, Austin, TX 78712, USA.

Daniel J McGrail (DJ)

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Yang Li (Y)

Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Science Park, Smithville, TX 78957, USA.

Erxi Wu (E)

Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Neuroscience Institute and Department of Neurosurgery, Baylor Scott & White Health, Temple, TX 76502, USA.
Department of Surgery, Texas A & M University Health Science Center, College of Medicine, Temple, TX 76508, USA.
Department of Pharmaceutical Sciences, Texas A & M University Health Science Center, College of Pharmacy, College Station, TX 77843, USA.

S Gail Eckhardt (SG)

Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Interdisciplinary Life Sciences Graduate Programs (ILSGP), College of Natural Sciences, The University of Texas at Austin, Austin, TX 78712, USA.

Nidhi Sahni (N)

Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Science Park, Smithville, TX 78957, USA.
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Program in Quantitative and Computational Biosciences (QCB), Baylor College of Medicine, Houston, TX 77030, USA.

S Stephen Yi (SS)

Department of Oncology, Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
Oden Institute for Computational Engineering and Sciences (ICES), The University of Texas at Austin, Austin, TX 78712, USA.
Interdisciplinary Life Sciences Graduate Programs (ILSGP), College of Natural Sciences, The University of Texas at Austin, Austin, TX 78712, USA.
Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX 78712, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH